Trade ILMN anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Illumina, Inc. (ILMN) is trading at US$215.59, down 5.31% today as of Aug 28, 16:00 EDT. The company has a market capitalisation of US$33.13B. Over the past 52 weeks, ILMN has traded between US$88.00 and US$231.81. On Syfe you can trade ILMN with $0 commission and add it to your watchlist.
| Previous close | US$227.69 |
|---|---|
| Market cap | US$33.13B |
| P/E ratio | 37.00 |
| 52-week range | US$88.00 – US$231.81 |
| Volume | 1.79M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Illumina, Inc.
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.
Year: 2000
Illumina, Inc. (ILMN) stock is trading at US$215.59, -5.31% from the previous close of US$227.69.
The market cap for Illumina, Inc. (ILMN) stock is approximately US$33.13B.
The price-to-earnings ratio for Illumina, Inc. (ILMN) is 37.00, based on the latest reported earnings.
The 52-week high for Illumina, Inc. (ILMN) stock is US$231.81.
The 52-week low for Illumina, Inc. (ILMN) stock is US$88.00.
Illumina, Inc. (ILMN) does not currently pay a dividend.
Stay on top of ILMN
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
